Laporan Laba Rugi (TTM)
Laporan Laba Rugi TC Biopharm (Holdings) Plc - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 3 | 3 | 1 |
| Change (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 47.15 | 32.04 | -12.87 | -14.77 | -50.00 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | ||||||||||||
| Change (%) | ||||||||||||
| % of Revenue | ||||||||||||
| Gross Operating Profit | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 3 | 3 | 1 |
| Change (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 47.15 | 32.04 | -12.87 | -14.77 | -50.00 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| SG&A | 2 | 2 | 2 | 2 | 3 | 5 | 7 | 8 | 8 | 8 | 7 | 7 |
| Change (%) | -6.57 | -7.03 | 29.80 | 24.96 | 69.57 | 41.03 | 6.93 | 4.86 | -4.49 | -13.96 | -2.80 | |
| % of Revenue | 111.53 | 104.20 | 96.87 | 125.74 | 157.12 | 266.42 | 375.72 | 273.04 | 216.83 | 237.69 | 239.95 | 466.48 |
| R&D | 7 | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 8 | 8 | 8 | 8 |
| Change (%) | -4.96 | -5.22 | 1.02 | 1.29 | 6.42 | 6.03 | 4.95 | 4.13 | 1.12 | 3.31 | -1.01 | |
| % of Revenue | 337.60 | 320.86 | 304.12 | 307.21 | 311.16 | 331.14 | 351.11 | 250.41 | 197.49 | 229.19 | 277.80 | 549.98 |
| OpEx | 9 | 8 | 8 | 9 | 9 | 12 | 14 | 15 | 16 | 16 | 15 | 15 |
| Change (%) | -5.37 | -5.68 | 7.99 | 8.43 | 27.61 | 21.63 | 5.97 | 4.51 | -1.70 | -4.64 | -2.32 | |
| % of Revenue | 448.05 | 423.98 | 399.91 | 431.87 | 468.28 | 597.56 | 726.83 | 523.45 | 414.32 | 467.41 | 522.97 | 1,021.68 |
| Operating Income | -7 | -6 | -6 | -7 | -7 | -10 | -12 | -12 | -12 | -12 | -12 | -13 |
| Change (%) | -6.92 | -7.43 | 10.66 | 10.97 | 35.10 | 25.98 | -0.59 | -1.99 | 1.85 | -1.88 | 8.95 | |
| % of Revenue | -348.05 | -323.98 | -299.91 | -331.87 | -368.28 | -497.56 | -626.83 | -423.45 | -314.32 | -367.41 | -422.97 | -921.68 |
| Interest Expense | -0 | -0 | -1 | -2 | -3 | -6 | -9 | -8 | -7 | -4 | -1 | -0 |
| Change (%) | 36.59 | 26.79 | 213.53 | 116.82 | 81.83 | 45.00 | -8.52 | -18.57 | -44.35 | -79.71 | -44.56 | |
| % of Revenue | -14.76 | -20.16 | -25.56 | -80.15 | -173.78 | -315.99 | -458.20 | -284.85 | -175.66 | -112.18 | -26.71 | -29.62 |
| Net Income | -5 | -5 | -5 | -11 | -14 | -12 | -10 | -4 | -1 | -2 | -1 | -4 |
| Change (%) | -2.65 | -2.72 | 112.74 | 23.45 | -11.64 | -13.18 | -58.71 | -69.46 | 67.85 | -33.41 | 151.15 | |
| % of Revenue | -275.84 | -268.54 | -261.23 | -555.76 | -686.12 | -606.24 | -526.37 | -147.71 | -34.17 | -65.82 | -51.42 | -258.31 |
Source: Capital IQ
